Tim Garnett

Tim Garnett is a seasoned medical and business executive with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as Chairman at Ophirex, Inc. since May 2021, Tim Garnett also holds positions as a Board Member at MapLight Therapeutics, Inc. and as an Equity Partner at Recode Ventures. Additional roles include Advisor positions at Lindus Health, Biolojic Design, Ltd., Ukko, and Xentria, Inc., along with involvement in the Advisory Panel of Cambridge Innovation Capital. Tim Garnett's previous experience includes more than two decades at Eli Lilly and Company, where responsibilities included Chief Medical Officer and Senior Vice President, overseeing Regulatory Affairs and drug development initiatives in international markets. Tim Garnett earned a Bachelor of Medicine, Bachelor of Surgery (MBBS) from St George's, University of London.